NCAPD2 plays a role in colorectal cancer through Ca2+/CAMKK/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis and can be used as a potential therapeutic target [21]. The gene discussed is PARP1; the disease is colorectal cancer.